Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study

Author: Sanz Miguel A.   Bermúdez Arancha   Rovira Montserrat   Besalduch Juan   Pascual Maria-Jesus   Nocea Gonzalo   Sanz-Rodríguez César    

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.21, Iss.5, 2005-05, pp. : 645-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content